Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a Canada-based biotech company. The Company is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. Its lead product, TeloView SMM, is a high-complexity molecular assay available for clinical use to provide information to physicians treating patients with Smoldering Multiple Myeloma. Through proprietary telomere-based analysis, TeloView SMM selects high-risk SMM patients who are likely to benefit from earlier treatment intervention while identifying the larger subset of low-risk SMM patients who have a more stable form of the disease and do not require immediate treatment. The TeloView SMM assay has a potential total addressable market of over 500,000 tests per year.

TSXV:TELO - Post by User

Telo Genomics Corp > It's a beautiful thing

<< Previous

Bullboard Posts

Next >>

Comment by Eoj123on Jan 25, 2021 1:09pm

175 Views

Post# 32376550

RE:It's a beautiful thing

I suspect we are seeing a lot of shares being sold by Flowerday as his 2 year escrow is over, this from Sept 2018: Good Riddance

Mr. Flowerday has resigned as CEO of the Company pursuant to a negotiated severance settlement of 2,000,000 common shares of 3DS which are subject to a two year escrow period. He will retain his existing options for a period of five years. Mr. Cassidy has resigned as CFO of the Company and will also retain his existing options for a period of five years.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver